Association of Biotechnology Led Enterprises

News

Merck and Baylor College of Medicine collaborate to advance COVID-19 vaccine manufacturing platform

The Merck-Baylor teams will improve the manufacturing platform for the CoV RBD219-N1 vaccine candidate, which was originally developed to target SARS in 2011-2016.

May 28, 2020

By : Team ABLE

Ajinomoto Bio-Pharma Services signs manufacturing agreement with Humanigen for Lenzilumab

Lenzilumab is currently being studied in a Phase III clinical trial in adult, hospitalized patients with COVID-19.

May 28, 2020

By : Team ABLE

DST-SERB supports study for identification of structure-based potential antivirals against COVID 19

In this study, a computer-based high throughput virtual screening approach will be used to identify antiviral molecules from different compound libraries

May 28, 2020

By : Team ABLE

ICMR formally inducts LifeCell for COVID-19 diagnostic testing

LifeCell has been formally inducted into the Government's approved laboratories to perform diagnostic and confirmatory tests for detecting Covid-19.

May 27, 2020

By : Team ABLE

US FDA approves intravenous artesunate to treat severe malaria

Prior to this approval, IV artesunate was only available to patients through the FDA's Expanded Access program, which allowed the U.S. CDC to provide IV artesunate to U.S. patients with severe malaria

May 27, 2020

By : Team ABLE